Molecular genetic markers of the risk of tension-type headache and migraine chronization development
https://doi.org/10.51523/2708-6011.2021-18-2-21
Abstract
Objective: to identify the molecular genetic criteria of the risk of tension-type headache and migraine chronization development.
Materials and methods. The detection of the results for the determination of allelic variants was carried out by means of horizontal electrophoresis using a molecular weight marker. The determination of the genotypes of the polymorphic variants of genes was carried out using high resolution melting PCR analysis.
Results. Based on the performed molecular genetic studies, it has been established that the statistically significant (p < 0.05) risk factors of tension-type headache chronization are: the identification of the A-allele and AA-genotype of the DBH3 polymorphism of the dopamine-beta-hydroxylase gene DBH, as well as the identification of the G-allele and the GG-genotype of the Intron3SNP polymorphism of the preprotachykinin gene TAC1. It has been found that the statistically significant (p < 0.05) risk factors of migraine chronization are: the identification of the A-allele, GA- and AA-genotypes of the G29A polymorphism of the serotonin transporter gene SLC6A4, as well as the identification of the G-allele and the GG-genotype of the rs7793277 polymorphism of the preprotachykinin gene TAC1.
Conclusion. The detection of these polymorphisms of the dopamine and preprotachykinin genes in the blood serum increases the risk of tension headache chronization by 1.395–1.991 times; the risk of migraine chronization by 1.235–1.395 times.
About the Authors
S. A. Kostiuk
Belarusian Medical Academy of Post-Graduate Education
Belarus
Belarus
Svetlana A. Kostiuk, DMedSc, Professor, Chief Researcher at the Science-Research Laboratory
Minsk
O. S. Poluyan
Belarusian Medical Academy of Post-Graduate Education
Belarus
Belarus
Olga S. Poluyan, PhD (Biol), Leading Researcher at the Science-Research Laboratory
Minsk
M. V. Simirski
Belarusian State Medical University
Belarus
Belarus
Maxim V. Simirski, student
Minsk
I. P. Marjenko
Republican Research and Clinical Center of Neurology and Neurosurgery
Belarus
Belarus
Irina P. Marjenko, PhD (Med), Leading Researcher at the Science-Research Laboratory of the Neurological Department
Minsk
References
1. Olesen J, Dodick DW, Ducros A, Evers S, First MB, Goadsby PJ, et al. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1). https://doi.org/10.1177/0333102417738202
2. Albers L, Straube A, Landgraf M, Filippopulos F, Heinen F, von Kries R. Migraine and tension type headache in adolescents at grammar school in Germany - burden of disease and health care utilization. J Headache Pain. 2015;16:52. https://doi.org/10.1186/s10194-015-0534-4
3. Menken M, Munsat TL, Toole JF. The global burden of disease study. Implications for neurology. Arch. Neurol. 2000;57(3):418–420.
4. Merikangas KL. Genetics of migraine and other headache. Curr. Opin. Neurol. 1996;9(2):202-205. https://doi.org/10.1097/00019052-199606000-00008
5. Russel MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ Clinical Research. 1995;311(7004):541–544. https://doi.org/10.1136/bmj.311.7004.541
6. Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM. Molecular genetics of migraine. Hum. Genet. 2009;126(1):115–132. https://doi.org/10.1007/s00439-009-0684-z
7. Borroni B, Brambilla C, Liberini P, Rao R, Archetti S, Gipponi S, et al. Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura. J. Headache Pain. 2005;6:182–184. https://doi.org/10.1007/s10194-005-0179-9
8. Di Giacomo V, Ferrante C, Ronci M, Ronci M, Di Valerio V, Rapino M, et al. Multiple pharmacological and toxicological investigations on Tanacetum parthenium and Salix alba extracts: Focus on potential application as anti-migraine agents. Food Chem Toxicol. 2019;133:110783. https://doi.org/10.1016/j.fct.2019.110783
9. Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia. 2007;27(11):1293–300. https://doi.org/10.1111/j.1468-2982.2007.01476.x
10. Gellynck E, Heyninck K, Andressen KW, Haegeman G, Levy FO, Vanhoenacker P et al. The serotonin 5-HT7 receptors: two decades of research. Exp Brain Res. 2013;230(4):555-568. https://doi.org/10.1007/s00221-013-3694-y
11. Hannon E, Weedon M, Bray N, O’Donovan M, Mill J. Pleiotropic Effects of Trait-Associated Genetic Variation on DNA Methylation: Utility for Refining GWAS Loci. Am J Hum Genet. 2017;100(6):954–959. https://doi.org/10.1016/j.ajhg.2017.04.013
12. Cherchi A, Stochino E, Piccardi MP, Zompo M. Role of dopaminergic system in migraine. J Headache Pain. 2001;2(1):47–49. https://doi.org/10.1007/s101940170009
13. Sicuteri F. Dopamine, the second putative protagonist in headache. Headache. 1977;17(3):129-131. https://doi.org/10.1111/j.1526-4610.1977.hed1703129.x
14. Mascia A, Afra J, Schoenen J. Dopamine and migraine: a review of pharmacological, biochemical, neurophysiological, and therapeutic data. Cephalalgia. 1998;18(4):174–182. https://doi.org/10.1046/j.1468-2982.1998.1804174.x
15. Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto F, Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci. 2004;74:1445–1463. https://doi.org/10.1016/j.lfs.2003.09.039
16. Kostyk SK, Kowall NW, Hauser SL. Substance P immunoreactive astrocytes are present in multiple sclerosis plaques. Brain Res. 1989;504(2):284–288. https://doi.org/10.1016/0006-8993(89)91369-3
17. Palma C, Minghetti L, Astolfi M, Ambrosini E, Silberstein FC, Manzini S, et al. Functional characterization of substance P receptors on culture human spinal chord astrocytes; synergism of substance P with cytokines in inducing interleukin-6 and prostaglandin-E2 production. Glia. 1997;21(2):183–193. https://doi.org/10.1002/(sici)1098-1136(199710)21:23.0.co;2-8
Review
For citations:
Kostiuk S.A., Poluyan O.S., Simirski M.V., Marjenko I.P. Molecular genetic markers of the risk of tension-type headache and migraine chronization development. Health and Ecology Issues. 2021;18(2):147-154. https://doi.org/10.51523/2708-6011.2021-18-2-21
Views: 411
Email this article 